Publications
70
Citations
832
Est. group size
—
Recurring co-author estimate
Active years
43
Publishing since 1984
Michael J. Ferguson studies childhood and young-adult cancers, with a focus on sarcomas (cancers of bone and soft tissue), brain tumors, and other solid tumors. Much of the work involves precision oncology\u2014using tumor genetics to match patients to targeted drugs\u2014and testing new drug combinations in laboratory and animal (xenograft) models. Studies range from molecular biomarker discovery to individual patient case reports.
Publication activity peaked around 2019-2020 and has continued at a steady, moderate pace since, averaging roughly 4-5 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Abstract 6179: Differential sensitivity of paired FUS-TFCP2+ RMS PDX models developed from tumor specimens obtained prior to and after ALK inhibitor therapy
Cancer Research · 2026
- Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2025
- Letter by Ferguson regarding article, “Revenues, costs, and contribution margins of major inpatient cardiovascular procedures within the Medicare population”
American Heart Journal · 2025
- Chondromyxoid Fibroma of the Nasal Cavity: A Benign Tumor in a Rare Head and Neck Location
Cureus · 2025
- BIOM-02. Examination of Growth Differentiation Factor 15 (GDF15) tumor expression as a potential prognostic biomarker in pediatric brain and solid tumors
Neuro-Oncology Pediatrics · 2025
- CT-derived body composition and differential association with age, TNM stage and systemic inflammation in patients with colon cancer
Scientific Reports · 2024
- Diagnostic Conundrum of a Sertoli Cell Tumor in a 2-Year-Old Girl with Peripheral Precocious Puberty and a Café-au-Lait Macule: A Case Report
Hormone Research in Paediatrics · 2024
- BIOM-10. EXAMINATION OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) EXPRESSION AS A POTENTIAL PROGNOSTIC BIOMARKER IN PEDIATRIC BRAIN TUMORS
Neuro-Oncology · 2024
- Pediatric precision oncology: “better three hours too soon than a minute too late”
Frontiers in Oncology · 2023
- Abstract 4487: Effective anti-tumor effect in a rare metastatic Wilms tumor xenograft by inhibition of RAS/PI3K hyperactivation
Cancer Research · 2023
- Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas
Cancers · 2022
- Abstract 2017: Therapeutic induction of replication stress in the context of salvage therapy in osteosarcoma
Cancer Research · 2022
- Immature teratoma in an adolescent with Proteus syndrome: A novel association
Clinical Case Reports · 2021
- 50 Years Ago in T J P
The Journal of Pediatrics · 2021
- Abstract 450: Systems biology approach provides rationale for dual-targeted inhibition of BET and CHK1 in aggressive pediatric osteosarcoma
Cancer Research · 2020
- Cancer Research×11
- Neurology×5
- PMC×5
- Figshare×5
- Cancers×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile